Serenoa repens (Permixon®) reduces intra- and postoperative complications of surgical treatments of benign prostatic hyperplasia. [electronic resource]
Producer: 20110301Description: 219-23 p. digitalISSN:- 0393-2249
- Aged
- Aged, 80 and over
- Androgen Antagonists -- therapeutic use
- Humans
- Intraoperative Complications -- prevention & control
- Male
- Middle Aged
- Plant Extracts -- therapeutic use
- Postoperative Complications -- prevention & control
- Preoperative Care -- methods
- Prostatectomy -- adverse effects
- Prostatic Hyperplasia -- surgery
- Serenoa
No physical items for this record
Publication Type: Journal Article; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.